These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1994547)

  • 1. Failure of prolyl-peptidyl isomerase to mediate cyclosporine suppression of intracellular activation signal generation.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1991 Feb; 51(2):509-13. PubMed ID: 1994547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
    Sigal NH; Dumont F; Durette P; Siekierka JJ; Peterson L; Rich DH; Dunlap BE; Staruch MJ; Melino MR; Koprak SL
    J Exp Med; 1991 Mar; 173(3):619-28. PubMed ID: 1997649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication.
    Kimball PM; Kerman RK; Van Buren CT; Lewis RM; Katz S; Kahan BD
    Transplantation; 1993 May; 55(5):1128-32. PubMed ID: 8497893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity of intracellular signals responsible for cell cycle progression to cyclosporine.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1990 Jan; 49(1):186-91. PubMed ID: 1689083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1991 Feb; 51(2):486-90. PubMed ID: 1825247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of immunosuppression by cyclosporins.
    Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.
    Takahashi N; Hayano T; Suzuki M
    Nature; 1989 Feb; 337(6206):473-5. PubMed ID: 2644542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A: new insights for cell biologists and biochemists.
    Hohman RJ; Hultsch T
    New Biol; 1990 Aug; 2(8):663-72. PubMed ID: 2282365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidyl-prolyl cis-trans isomerase of Bacillus subtilis: identification of residues involved in cyclosporin A affinity and catalytic efficiency.
    Göthel SF; Herrler M; Marahiel MA
    Biochemistry; 1996 Mar; 35(11):3636-40. PubMed ID: 8639516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl-prolyl cis-trans isomerase from Bacillus subtilis. A prokaryotic enzyme that is highly sensitive to cyclosporin A.
    Herrler M; Bang H; Brune K; Fischer G; Marahiel MA
    FEBS Lett; 1992 Sep; 309(3):231-4. PubMed ID: 1516692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
    Fischer G; Wittmann-Liebold B; Lang K; Kiefhaber T; Schmid FX
    Nature; 1989 Feb; 337(6206):476-8. PubMed ID: 2492638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine's dual mechanism of action in inhibiting generation of the cytoplasmic activation signal and the nuclear response thereto.
    Citterio F; Kahan BD
    Transplantation; 1991 Jun; 51(6):1248-57. PubMed ID: 1904664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct forms of peptidylprolyl-cis-trans-isomerase are expressed separately in periplasmic and cytoplasmic compartments of Escherichia coli cells.
    Hayano T; Takahashi N; Kato S; Maki N; Suzuki M
    Biochemistry; 1991 Mar; 30(12):3041-8. PubMed ID: 2007139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
    Citterio F; Kahan BD
    Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity.
    Khattab A; Pica-Mattoccia L; Klinkert MQ; Wenger R; Cioli D
    Exp Parasitol; 1998 Sep; 90(1):103-9. PubMed ID: 9709036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.
    el Rouby S; Shi Y; Reem GH
    Clin Exp Immunol; 1992 Jul; 89(1):136-42. PubMed ID: 1628422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition.
    Zydowsky LD; Etzkorn FA; Chang HY; Ferguson SB; Stolz LA; Ho SI; Walsh CT
    Protein Sci; 1992 Sep; 1(9):1092-9. PubMed ID: 1338979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin analogs modified in the 3,7,8-positions: substituent effects on peptidylprolyl isomerase inhibition and immunosuppressive activity are nonadditive.
    Hu MK; Badger A; Rich DH
    J Med Chem; 1995 Oct; 38(21):4164-70. PubMed ID: 7473543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.